Discover the latest insights on the diagnosis and management of pleural infection in this latest RESP seminar in the series.
Recorded Monday 8 December 2025
This insightful and educational session is part of the RESP (Respiratory Expert Speaker and Patient) webinar series, proudly presented by Respiratory Futures, INSPIRE and Asthma + Lung UK.
This webinar features expert speaker Professor Najib Rahman and patient representative Nick Totterdell.
This presentation summarised cutting-edge evidence on the diagnosis and management of pleural infection, which is both common and associated with poor outcomes. Increasing understanding of the underlying biology and microbiology has led to new treatment options, and potential future directions.
Professor Najib Rahman
Najib Rahman directs the Oxford Respiratory Trials Unit and works clinically as a pleural specialist. Having qualified in Oxford, he underwent the medical SHO rotation at Queen’s Medical Centre, Nottingham, and re-joined Oxford as a Specialist Registrar in 2003. He was appointed Director of the Oxford Respiratory Trials Unit and Consultant Lead for Pleural Disease in Oxford in 2011. He was appointed as Professor of Respiratory Medicine in 2018, and runs randomised and observational studies in pleural infection, pneumothorax and malignant pleural effusion. He is trained in Thoracoscopy, Thoracic Ultrasound and Clinical Trials methodology, and has published over 300 papers with over 20,000 citations and an H-index of 67. He is co-chair of the BTS Pleural Guidelines 2023, Chair of the BTS Pleural Intervention Committee 2023, Chair of multiple ERS guidelines on pleural disease, Senior NIHR Investigator and National Speciality Lead for Respiratory Research for the NIHR Research Delivery Network.
Mesothelioma is a rare type of lung cancer, typically caused by Asbestos inhalation and commonly...
The GIRFT Tuberculosis (TB) report is a comprehensive, data-driven national review of TB services...
In 2020 the COVID-19 pandemic hit the global population, causing lockdowns and economic...
This guideline covers diagnosing, assessing, and treating community-acquired and hospital-acquired...
COPD is the second most common cause for hospital admission and the third leading cause of death...